Jeffrey W. Albers Kymera Therapeutics, Inc. (KYMR) insider trading activity
Jeffrey W. Albers is of Kymera Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KYMR, which is worth approximately $0. The most recent transaction as insider was on Aug 26, 2024, when has been sold 5,000 shares (Common Stock) at a price of $49.1 per share, resulting in proceeds of $245,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
n/a
12M change
Total Value Held
$0
Jeffrey W. Albers Transaction History
Also insider at
JWA
Jeffrey W. Albers
Cambridge, MA